2005

Segmedica's methodology for delving 'behind the curtain' of verbal responses to reveal what truly motivates physicians.

Preliminary results from The Drug Risk Survey, which posed questions about the FDA's proposed Drug Watch program as well as the Drug Risk Advisory System proposed independently.

This article reviews Imedex's approach to developing CME programs.

This is the first article in a continuing series that will keep you up-to-date on Blog topics from a variety of pharma-related Blogs created by individuals as well as pharma companies.

Instead of fancy, expensive ads or PR campaigns, why don't pharma companies interview a few employees and let us hear directly from them?

All marketers are bullshitters! What are some noteworthy examples of pharmaceutical marketing bullshit? How does marketing bullshit hurt the industry?

Nearly 70 people showed up at the Second Annual Networking Dinner Reception on May 18, 2005, in Metuchen, New Jersey. Attendees spent several hours networking, enjoying dinner, and brain-storming ideas about how to improve the Network and the services offered.

Taking a page from the Homeland Security Advisory system, the author proposes a color-coded system for notifying the public about drug risks and links the levels of risk with levels of restrictions on DTC advertising.

This article reviews Medigent Thought Leader, a Web-based software suite designed to dramatically improve a pharma company's communications with Key Opinion Leaders.

This article summarizes a panel discussion at a recent Pharmaceutical Executive Annual Marketing Summit in Philadelphia.